A detailed history of Alliancebernstein L.P. transactions in Nevro Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 51,570 shares of NVRO stock, worth $233,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,570
Previous 52,870 2.46%
Holding current value
$233,096
Previous $445,000 35.51%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.71 - $10.1 $6,123 - $13,130
-1,300 Reduced 2.46%
51,570 $287,000
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $128,713 - $219,750
16,170 Added 44.06%
52,870 $445,000
Q1 2024

May 14, 2024

SELL
$13.56 - $20.78 $61,020 - $93,510
-4,500 Reduced 10.92%
36,700 $529,000
Q1 2023

May 15, 2023

SELL
$30.17 - $41.11 $6,365 - $8,674
-211 Reduced 0.51%
41,200 $1.49 Million
Q4 2022

Feb 14, 2023

SELL
$36.43 - $49.4 $141,676 - $192,116
-3,889 Reduced 8.58%
41,411 $1.64 Million
Q2 2022

Aug 15, 2022

SELL
$40.85 - $77.67 $11,192 - $21,281
-274 Reduced 0.6%
45,300 $1.99 Million
Q1 2022

May 13, 2022

BUY
$59.95 - $92.06 $22,421 - $34,430
374 Added 0.83%
45,574 $3.3 Million
Q3 2021

Nov 10, 2021

SELL
$101.99 - $166.36 $2.44 Million - $3.98 Million
-23,921 Reduced 34.61%
45,200 $5.26 Million
Q2 2021

Jul 30, 2021

SELL
$141.6 - $179.06 $198,240 - $250,684
-1,400 Reduced 1.99%
69,121 $11.5 Million
Q1 2021

May 06, 2021

SELL
$132.81 - $182.18 $385,149 - $528,322
-2,900 Reduced 3.95%
70,521 $9.84 Million
Q3 2020

Nov 12, 2020

SELL
$114.09 - $145.51 $1.31 Million - $1.67 Million
-11,459 Reduced 13.5%
73,421 $10.2 Million
Q2 2020

Aug 13, 2020

BUY
$89.45 - $129.85 $1.65 Million - $2.39 Million
18,410 Added 27.7%
84,880 $10.1 Million
Q1 2020

May 14, 2020

BUY
$70.23 - $144.31 $1.6 Million - $3.29 Million
22,770 Added 52.11%
66,470 $6.65 Million
Q4 2019

Feb 18, 2020

BUY
$76.41 - $117.54 $145,179 - $223,326
1,900 Added 4.55%
43,700 $5.14 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $3.8 Million - $4.39 Million
-65,500 Reduced 61.04%
41,800 $2.71 Million
Q1 2019

May 14, 2019

SELL
$35.52 - $62.62 $781,440 - $1.38 Million
-22,000 Reduced 17.01%
107,300 $6.71 Million
Q4 2018

Feb 13, 2019

SELL
$35.43 - $56.29 $2.46 Million - $3.91 Million
-69,527 Reduced 34.97%
129,300 $5.03 Million
Q3 2018

Nov 08, 2018

SELL
$44.22 - $75.47 $49.4 Million - $84.4 Million
-1,117,761 Reduced 84.9%
198,827 $11.3 Million
Q2 2018

Aug 13, 2018

SELL
$72.38 - $92.5 $14.9 Million - $19 Million
-205,460 Reduced 13.5%
1,316,588 $105 Million
Q1 2018

May 14, 2018

BUY
$69.46 - $88.57 $399,256 - $509,100
5,748 Added 0.38%
1,522,048 $132 Million
Q4 2017

Feb 13, 2018

BUY
$65.94 - $93.31 $2.82 Million - $4 Million
42,823 Added 2.91%
1,516,300 $105 Million
Q3 2017

Nov 13, 2017

BUY
$80.87 - $91.08 $119 Million - $134 Million
1,473,477
1,473,477 $134 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.